SART3 antibody - N-terminal region
Product Sizes
25ul
£177.00
ARP39128-T100-25UL
100 ul
£373.00
ARP39128-T100-100UL
About this Product
- SKU:
- ARP39128-T100
- Additional Names:
- P100; p110; DSAP1; TIP110; p110(nrb); RP11-13G14
- Clonality:
- Polyclonal
- Concentration:
- 1.0 mg/ml
- Extra Details:
- SART3 is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. SART3 is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This protein is thought to be involved in the regulation of mRNA splicing.
- Gene Details:
- Squamous cell carcinoma antigen recognized by T cells 3
- Host:
- Rabbit
- Immunogen:
- The immunogen is a synthetic peptide directed towards the N terminal region of human SART3
- Molecular Weight:
- 40kDa
- Protein Details:
- Squamous cell carcinoma antigen recognized by T-cells 3
- Purification:
- Protein A purified
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- For short term use; store at 2-8C up to 1 week. For long term storage; store at -20C in small aliquots to prevent freeze-thaw cycles.
- Supplier:
- Aviva Systems Biology
- Type:
- Antibodies: Polyclonal Antibody
- Manufacturer's Data Sheet:html_datasheet.php
